Shandong Sanyuan Biotechnology Co Ltd
SZSE:301206
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Shandong Sanyuan Biotechnology Co Ltd
Net Income (Common)
Shandong Sanyuan Biotechnology Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Shandong Sanyuan Biotechnology Co Ltd
SZSE:301206
|
Net Income (Common)
¥105m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Inner Mongolia Yili Industrial Group Co Ltd
SSE:600887
|
Net Income (Common)
¥8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
Net Income (Common)
¥7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
|
|
Yihai Kerry Arawana Holdings Co Ltd
SZSE:300999
|
Net Income (Common)
¥2.5B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Muyuan Foods Co Ltd
SZSE:002714
|
Net Income (Common)
¥9.8B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
26%
|
|
|
Wens Foodstuff Group Co Ltd
SZSE:300498
|
Net Income (Common)
¥2.2B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-13%
|
|
Shandong Sanyuan Biotechnology Co Ltd
Glance View
Shandong Sanyuan Biotechnology Co Ltd is a CN-based company operating in Food Products industry. The company is headquartered in Binzhou, Shandong and currently employs 382 full-time employees. The company went IPO on 2022-02-10. Shandong Sanyuan Biotechnology Co Ltd is a China-based company mainly engaged in the production and sales of new sweetener products. The firm's main products are erythritol and compound sugar. The compound sugar products include momordica grosvenori compound sugar, stevia compound sugar, sucralose compound sugar and others. The firm's products are sold to America, Europe, Africa, Oceania and other regions.
See Also
What is Shandong Sanyuan Biotechnology Co Ltd's Net Income (Common)?
Net Income (Common)
105m
CNY
Based on the financial report for Dec 31, 2024, Shandong Sanyuan Biotechnology Co Ltd's Net Income (Common) amounts to 105m CNY.
What is Shandong Sanyuan Biotechnology Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-5%
Over the last year, the Net Income (Common) growth was 87%. The average annual Net Income (Common) growth rates for Shandong Sanyuan Biotechnology Co Ltd have been -42% over the past three years , -5% over the past five years .
